bioMerieux

biomerieux.com · France

bioMérieux is a global in vitro diagnostics company that designs, manufactures, and markets diagnostic systems, reagents, and software used to detect diseases and contaminants in clinical, industrial, and food safety settings. It serves hospitals, private laboratories, pharmaceutical and food companies, and public health organizations, generating revenue through the sale of instruments, consumables, and associated services. The company focuses on microbiology, infectious disease diagnostics, and syndromic testing solutions.

  • Electronic Health Records
Revenue
$3.8B
Employees
14,000
Founded
1963
Headquarters
France

What 17 Arbolus experts think of bioMerieux

NPS scores are predominantly in the 8–10 range, with strong outperformance by healthcare and pharma customers. Renewal intent is affirmed by all customers disclosing it, and the stickiness observed with most customers in the MoreThan1Year stage. Key themes are high satisfaction, reliability, and customer retention, punctuated by limited uncertainty among a small subset of Influencers.Overall Customer Sentiment: Positive

Who reviewed bioMerieux

Total customers 17 17 current · 0 former
Reviews growth +9 in six months
Seniority of respondents
  • C-Suite 82% (14)
  • Director 6% (1)
  • Manager 12% (2)
Operations Manager C-Suite NPS 9
Operations Manager C-Suite NPS 10 Will renew
Strategy Partner C-Suite NPS 6

Employer names and spend open once the report publishes.

Tell us when the bioMerieux report publishes.

We'll email you once the full customer report is ready, with employer names, spend and every written answer. No account needed.

Notify me

Sentiment

58 Net Promoter Score, from 17 scored reviews
  • Promoters 12
  • Passives 3
  • Detractors 2

Cumulative NPS by month

+0 over 5 months
  • Jan 9
  • Feb 8
  • May 8
  • Jun 9
  • Sep 9

Net Promoter Score across 1 reviews, accumulated up to each month. Category median 58 across 1 companies.

Written answers and themes publish with the full report.

Renewal intent

Plan to renew 50%
  • Will renew 4
  • Undecided 4
  • Not renewing 0

Plan to renew, by seniority

  • C-Suite 43% 7 answers
  • Manager 100% 1 answer
  • 8.8/10 Average score from customers who will renew
  • 8.3/10 Average score from undecided customers

For people who use bioMerieux

Do you use bioMerieux at work?

Share your software review and get matched to paid projects. Arbolus pays you every time a client reads your review.

  • 17 customers of bioMerieux have already contributed
Share your experience

Takes a few minutes. Your identity stays anonymous.